271261-71-3 Usage
General Description
Benzoic acid, 2,4-dihydroxy-5-nitro-, methyl ester (9CI) is a chemical compound with the molecular formula C8H7NO5. It is commonly used as a chemical intermediate and in the synthesis of pharmaceuticals, dyes, and fragrances. Benzoic acid, 2,4-dihydroxy-5-nitro-, methyl ester (9CI) has been identified as a potential mutagen and has been found to exhibit cytotoxic and antimicrobial properties. Additionally, it is known for its antioxidant and anti-inflammatory effects. The methyl ester form of benzoic acid, 2,4-dihydroxy-5-nitro- has been studied for its potential therapeutic applications in conditions such as cancer and inflammation. However, its toxicity and potential health hazards should be carefully considered and further studied before any widespread applications.
Check Digit Verification of cas no
The CAS Registry Mumber 271261-71-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,1,2,6 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 271261-71:
(8*2)+(7*7)+(6*1)+(5*2)+(4*6)+(3*1)+(2*7)+(1*1)=123
123 % 10 = 3
So 271261-71-3 is a valid CAS Registry Number.
271261-71-3Relevant articles and documents
An efficient entry to amino-substituted resorcylic acid derivatives for the synthesis of platensimycin and analogues
Heretsch, Philipp,Giannis, Athanassios
, p. 2614 - 2616 (2007)
An efficient entry to protected amino-substituted resorcylic acid derivatives, methyl 3- or 5-amino-2,4-bis(methoxymethoxy)benzoate, is reported. Both derivatives can be used for the synthesis of platensimycin and its analogues. Georg Thieme Verlag Stuttg
IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF
-
Page/Page column 42-43, (2020/08/22)
Provided herein are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
CAVITY-CONTAINING OLIGOMERS AND POLYMERS EFFECTIVE IN CRYOPRESERVATION
-
Paragraph 0033; 0116, (2019/06/09)
The present invention provides compositions and methods for cryopreservation utilizing aromatic cavity-containing oligomers and polymers that contain structural motifs capable of shape-inducing intramolecular bonding to form cavities. The cavity-containin